EuroPCR 2024: Late-Breaking Science Video Collection

Published: 20 May 2024

  • Views:

    Views Icon 1043

  • Likes:

    Heart Icon 7
Average (ratings)
No ratings
Your rating

Overview

Our regular review series View From the Thoraxcenter, hosted by Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcentre, Erasmus MC, Rotterdam, NL) dives deep into the late-breaking trials of EuroPCR 2023, spotlighting the impactful data.

For short, concise coverage of the key data revealed, our accessible Expert Interviews were conducted with select faculty, focussing on the results, applicability and impact on future research. 

Hear commentary on the practice-changing trials of EuroPCR 2024 from selected faculty in our Highlights Reviews.

More from this programme

Part 1

Expert Interviews

6 sessions
Self-Expandable Vs Balloon-Expandable Valves & General Vs Local Anesthesia in TAVI: SOLVE-TAVI Watch now
Influence of Pathophysiological Patterns of CAD on PCI Watch now
Ancillary SMART Trial Analyses Watch now
Impact of Diabetes Severity After Abluminus DES+ Stent: ABILITY Watch now
TAVR Vs SAVR in Younger Low-Risk Patients with Severe Aortic Valve Stenosis: NOTION-2 Watch now
1M DAPT Followed by 5M Ticagrelor Monotherapy in ACS with DCB: CAGEFREE II Watch now

Part 2

View from the Thoraxcenter

2 sessions
View from the Thoraxcenter: What's Hot at EuroPCR 24? Watch now
View from the Thoraxcenter: EuroPCR 24 Wrap Up - Part 1 Watch now

Part 3

Highlights Reviews

2 sessions
5 Trials That Will Change My Practice With Dr Mirvat Alasnag Watch now
4 Trials That Will Change My Practice with Dr Bernardo Cortese Watch now

About the episode

EuroPCR 2024 - We are joined by Dr Mirvat Alasnag (King Fahd Armed Forces Hospital, SA) for a concise and insightful summary of the late-breaking trials that are expected to have an impact on structural heart disease care.

Trials covered in detail include:

  • IRONMAN II
  • DESyne BDS Plus
  • NOTION II
  • LANDMARK
  • PINNACLE

Recorded onsite at EuroPCR 2024, Paris

Faculty Biographies

Mirvat Alasnag

Mirvat Alasnag

Director of Catheterization Laboratory

Dr Mirvat Alasnag is an editorial board member of Interventional Cardiology: Reviews, Research, Resources (ICR3), joining the board in October 2020 and is also on the editorial board for US Cardiology Review (USC).

Dr Mirvat Alasnag is the Director of the Catheterization Laboratory at the King Fahad Armed Forces Hospital in Jeddah, Saudi Arabia. She was the first female interventional cardiologist in the Gulf region and has since represented women on multiple medical committees, including the Saudi Arabian Cardiac Interventional Society Board & the EAPCI Women’s Steering Committee. She is the current ACCWIC International Working Group Chair and an SCAI WIN member.

Dr Alasnag trained in Clinical Cardiology and Interventional Cardiology at Loma Linda University Medical Center (Loma Linda, California) and Harper University Hospital, Detroit Medical Center (Detroit, Michigan), respectively. Since her graduation in 2009 to date, she has been…

View full profile

Comments

You must be to comment. If you are not registered, you can register here.